218 related articles for article (PubMed ID: 37167725)
1. N6-methyladenosine (m6A) in cancer stem cell: From molecular mechanisms to therapeutic implications.
Wang L; Tang Y
Biomed Pharmacother; 2023 Jul; 163():114846. PubMed ID: 37167725
[TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
Wang D; Zhang Y; Li Q; Zhang A; Xu J; Li Y; Li W; Tang L; Yang F; Meng J
Biomed Pharmacother; 2023 Nov; 167():115477. PubMed ID: 37696088
[TBL] [Abstract][Full Text] [Related]
3. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Qin S; Mao Y; Wang H; Duan Y; Zhao L
Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine (m6A) RNA modification in cancer stem cells.
Ma Z; Ji J
Stem Cells; 2020 Sep; ():. PubMed ID: 32985068
[TBL] [Abstract][Full Text] [Related]
5. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
Lin H; Wang Y; Wang P; Long F; Wang T
Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
[TBL] [Abstract][Full Text] [Related]
6. Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate.
Xu Y; Liu J; Chen WJ; Ye QQ; Chen WT; Li CL; Wu HT
Front Cell Dev Biol; 2020; 8():561703. PubMed ID: 33072746
[TBL] [Abstract][Full Text] [Related]
7. Effects of N6-methyladenosine modification on metabolic reprogramming in digestive tract tumors.
Yu L; Gao Y; Bao Q; Xu M; Lu J; Du W
Heliyon; 2024 Jan; 10(2):e24414. PubMed ID: 38293446
[TBL] [Abstract][Full Text] [Related]
8. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
9. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
10. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
11. Functions of N6-methyladenosine and its role in cancer.
He L; Li H; Wu A; Peng Y; Shu G; Yin G
Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine links RNA metabolism to cancer progression.
Dai D; Wang H; Zhu L; Jin H; Wang X
Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells.
Wang C; Danli Ma ; Yu H; Zhuo Z; Ye Z
Heliyon; 2023 Mar; 9(3):e14001. PubMed ID: 36915498
[TBL] [Abstract][Full Text] [Related]
14. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
15. RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy.
Kumari S; Kumar S; Muthuswamy S
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1621-1633. PubMed ID: 35796777
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine functions and its role in skin cancer.
Ran Y; Yan Z; Jiang B; Liang P
Exp Dermatol; 2023 Jan; 32(1):4-12. PubMed ID: 36314059
[TBL] [Abstract][Full Text] [Related]
17. Roles of N6-Methyladenosine Demethylase FTO in Malignant Tumors Progression.
Zheng QK; Ma C; Ullah I; Hu K; Ma RJ; Zhang N; Sun ZG
Onco Targets Ther; 2021; 14():4837-4846. PubMed ID: 34556998
[TBL] [Abstract][Full Text] [Related]
18. Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer.
Qu X; Zhang Y; Sang X; Ren D; Zhao H; Wong STC
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804965
[TBL] [Abstract][Full Text] [Related]
19. Novel positioning from obesity to cancer: FTO, an m
Chen J; Du B
J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
[TBL] [Abstract][Full Text] [Related]
20. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
